Discover how molecular testing supported the rapid development of SARS-CoV-2 vaccines.

Accurate molecular testing was essential for evaluating vaccine safety, monitoring viral dynamics, and supporting clinical decision-making throughout the COVID-19 pandemic. This video examines the role of RT-qPCR and sequencing technologies in vaccine clinical trials, highlighting key considerations for assay development, analytical performance, and monitoring emerging viral variants.

Key topics include:

• The role of RT-qPCR in SARS-CoV-2 vaccine clinical trials
• Key considerations for molecular assay development and analytical performance
• How sequencing technologies support viral variant monitoring
• Strategies for adapting molecular testing to emerging viral variants

As infectious disease research continues to evolve, robust molecular testing remains critical for supporting vaccine development and generating reliable clinical trial data. Learn how RT-qPCR and sequencing technologies help advance vaccine research and respond to an ever-changing viral landscape.